Heparanase expression correlates with invasion and poor prognosis in gastric cancers

Laboratory Investigation

Volumn 83, Issue 5, 2003, Pages 613-622

  Takaoka, Munenori ^a   Naomoto, Yoshio ^a   Ohkawa, Takaomi ^a   Uetsuka, Hirokazu ^a   Shirakawa, Yasuhiro ^a   Uno, Futoshi ^a   Fujiwara, Toshiyoshi ^a   Gunduz, Mehmet ^a   Nagatsuka, Hitoshi ^a   Nakajima, Motowo ^b   Tanaka, Noriaki ^a   Haisa, Minoru ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NOVARTIS PHARMA K K   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARANASE; MESSENGER RNA; PROTEOHEPARAN SULFATE;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; METASTASIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

EID: 0037799669     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000067482.84946.BD     Document Type: Article

References (36)

1. Adachi Y, Itoh F, Yamamoto H, Matsuno K, Arimura Y, Kusano M, Endoh T, Hinoda Y, Oohara M, Hosokawa M, and Imai K (1998). Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int J Oncol 13:1031-1035.
2. Ajani JA, Mansfield PF, and Ota DM (1995). Potentially resectable gastric carcinoma: Current approaches to staging and preoperative therapy. World J Surg 19:216-220.
3. Andela VB, Schwarz EM, Puzas JE, O'Keefe RJ, and Rosier RN (2000). Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappa B. Cancer Res 60:6557-6562.
4. Bartlett MR, Underwood PA, and Parish CR (1995). Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: Evidence for cytokine dependence and detection of a novel sulfatase. Immunol Cell Biol 73(2):113-124.
5. Carneiro F and Sobrinho-Simoes M (2000). The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 88:238-240.
6. Endo K, Maejara U, Baba H, Tokunaga E, Koga T, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Nakajima M, and Sugimachi K (2001). Heparanase gene expression and metastatic potential in human gastric cancer. Anticancer Res 21(5):3365-3369.
7. Finkel E (1999). Potential target found for antimetastasis drugs. Science 285:33-34.
8. Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, and Pappo O (2000). Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma: Evidence for its role in colonic tumorigenesis. Am J Pathol 157:1167-1175.
9. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, and Parish CR (1999). Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5:803-809.
10. Inoue H, Mimori K, Utsunomiya T, Sadanaga N, Barnard GF, Ueo H, and Mori M (2001). Heparanase expression in clinical digestive malignancies. Oncol Rep 8:539-542.
11. Kussie PH, Hulmes JD, Ludwig DL, Patel S, Navarro EC, Seddon AP, Giorgio NA, and Bohlen P (1999). Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun 261:183-187.
12. Lapierre F, Holme K, Lam L, Tressler RJ, Storm N, Wee J, Stack RJ, Castellot J, and Tyrrell DJ (1996). Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. Glycobiology 6:355-366.
13. Marchetti D, Li J, and Shen R (2000). Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. Cancer Res 60:4767-4770.
14. Miao HQ, Elkin M, Aingorn E, Ishai-Michaeli R, Stein CA, and Vlodavsky I (1999). Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer 83:424-431.
15. Mollinedo F, Nakajima M, Llorens A, Barbosa E, Callejo S, Gajate C, and Fabra A (1997). Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochem J 327:917-923.
16. Nakajima M (1992). Heparanases and tumor metastasis. Tanpakushitsu Kakusan Koso 37:1753-1758.
17. Nakajima M, DeChavigny A, Johnson CE, Hamada J, Stein CA, and Nicolson GL. Suramin (1991). A potent inhibitor of melanoma heparanase and invasion. J Biol Chem 266:9661-9666.
18. Nakajima M, Irimura T, Di Ferrante D, Di Ferrante N, and Nicolson GL (1983). Heparan sulfate degradation: Relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 220:611-613.
19. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, and Nakano H (1999). The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 85:1894-1902.
20. Nicolson GL, Irimura T, Nakajima M, and Estrada J (1983). Metastatic cell attachment to and invasion of vascular endothelium and its underlying basal lamina using endothelial cell monolayers. Symp Fundam Cancer Res 36:145-167.
21. Parish CR, Freeman C, Brown KJ, Francis DJ, and Cowden WB (1999). Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 59:3433-3441.
22. Parish CR, Freeman C, and Hulett MD (2001). Heparanase: A key enzyme involved in cell invasion. Biochim Biophys Acta 1471:M99-M108.
23. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K, and Edwards BK (2000). The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88:2398-2424.
24. Schwartz GK (1996). Invasion and metastases in gastric cancer: In vitro and in vivo models with clinical correlations. Semin Oncol 23:316-324.
25. Senota A, Itoh F, Yamamoto H, Adachi Y, Hinoda Y, and Imai K (1998). Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer. Clin Exp Metastasis 16:313-321.
26. Shirakawa Y, Naomoto Y, Kimura M, Kawashima R, Yamatsuji T, Tamaki T, Hamada M, Haisa M, and Tanaka N (2000). Topological analysis of p21 WAF1/CIP1 expression in esophageal squamous dysplasia. Clin Cancer Res 6(2):541-550.
27. Tacchini L, Dansi P, Matteucci E, and Desiderio MA (2000). Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2. Exp Cell Res 256:272-281.
28. Tahara E (1995). Molecular biology of gastric cancer. World J Surg 19:484-488; discussion 489-490.
29. Tahara E (2000). Molecular aspects of invasion and metastasis of stomach cancer. Verh Dtsch Ges Pathol 84:43-49.
30. Toyoshima M and Nakajima M (1999). Human heparanase: Purification, characterization, cloning, and expression. J Biol Chem 274:24153-24160.
31. Uno F, Fujiwara T, Takata Y, Ohtani S, Katsuda K, Takaoka M, Ohkawa T, Naomoto Y, Nakajima M, and Tanaka N (2001). Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells. Cancer Res 61(21):7855-7860.
32. Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P, and Fuks Z (1991). Extracellular sequestration and release of fibroblast growth factor: A regulatory mechanism? Trends Biochem Sci 16:268-271.
33. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, and Pecker I (1999). Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis. Nat Med 5:793-802.
34. Walch ET and Marchetti D (1999). Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells. Clin Exp Metastasis 17:307-314.
35. Yamamoto H, Adachi Y, Itoh F, Iku S, Matsuno K, Kusano M, Arimura Y, Endo T, Hinoda Y, Hosokawa M, and Imai K (1999). Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 59:3313-3316.
36. Yamamoto H, Itoh F, Hinoda Y, Senota A, Yoshimoto M, Nakamura H, Imai K, and Yachi A (1994). Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. Biochem Biophys Res Commun 201:657-664.